Yee K - Search Results

1

Effect of different durations of ketoconazole dosing on the single-dose pharmacokinetics of midazolam: shortening the paradigm.

Stoch SA, Friedman E, Maes A, Yee K, Xu Y, Larson P, Fitzgerald M, Chodakewitz J, Wagner JA. Stoch SA, et al. Among authors: yee k. J Clin Pharmacol. 2009 Apr;49(4):398-406. doi: 10.1177/0091270008331133. Epub 2009 Feb 26. J Clin Pharmacol. 2009. PMID: 19246722 Clinical Trial.

2

Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men.

Sun H, Kennedy WP, Wilbraham D, Lewis N, Calder N, Li X, Ma J, Yee KL, Ermlich S, Mangin E, Lines C, Rosen L, Chodakewitz J, Murphy GM. Sun H, et al. Sleep. 2013 Feb 1;36(2):259-67. doi: 10.5665/sleep.2386. Sleep. 2013. PMID: 23372274 Free PMC article. Clinical Trial.

3

A randomized, double-blind, placebo-controlled, short-term monotherapy study of doravirine in treatment-naive HIV-infected individuals.

Schürmann D, Sobotha C, Gilmartin J, Robberechts M, De Lepeleire I, Yee KL, Guo Y, Liu R, Wagner F, Wagner JA, Butterton JR, Anderson MS. Schürmann D, et al. AIDS. 2016 Jan 2;30(1):57-63. doi: 10.1097/QAD.0000000000000876. AIDS. 2016. PMID: 26372481 Clinical Trial.

4

Psychomotor effects, pharmacokinetics and safety of the orexin receptor antagonist suvorexant administered in combination with alcohol in healthy subjects.

Sun H, Yee KL, Gill S, Liu W, Li X, Panebianco D, Mangin E, Morrison D, McCrea J, Wagner JA, Troyer MD. Sun H, et al. J Psychopharmacol. 2015 Nov;29(11):1159-69. doi: 10.1177/0269881115609015. Epub 2015 Oct 13. J Psychopharmacol. 2015. PMID: 26464455 Clinical Trial.

5

Moderate Hepatic Impairment Does Not Affect Doravirine Pharmacokinetics.

Khalilieh S, Yee KL, Liu R, Fan L, Sanchez RI, Auger P, Triantafyllou I, Stypinski D, Lasseter KC, Marbury T, Iwamoto M. Khalilieh S, et al. J Clin Pharmacol. 2017 Jun;57(6):777-783. doi: 10.1002/jcph.857. Epub 2016 Dec 27. J Clin Pharmacol. 2017. PMID: 28026013 Clinical Trial.

6

The Effect of Food on Doravirine Bioavailability: Results from Two Pharmacokinetic Studies in Healthy Subjects.

Behm MO, Yee KL, Liu R, Levine V, Panebianco D, Fackler P. Behm MO, et al. Clin Drug Investig. 2017 Jun;37(6):571-579. doi: 10.1007/s40261-017-0512-5. Clin Drug Investig. 2017. PMID: 28349328 Clinical Trial.

7

The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects.

Yee KL, Khalilieh SG, Sanchez RI, Liu R, Anderson MS, Manthos H, Judge T, Brejda J, Butterton JR. Yee KL, et al. Clin Drug Investig. 2017 Jul;37(7):659-667. doi: 10.1007/s40261-017-0513-4. Clin Drug Investig. 2017. PMID: 28353169

8

A Randomized Trial to Assess the Effect of Doravirine on the QTc Interval Using a Single Supratherapeutic Dose in Healthy Adult Volunteers.

Khalilieh SG, Yee KL, Fan L, Liu R, Heber W, Dunzo E, Triantafyllou I, Hussaini A, Iwamoto M. Khalilieh SG, et al. Clin Drug Investig. 2017 Oct;37(10):975-984. doi: 10.1007/s40261-017-0552-x. Clin Drug Investig. 2017. PMID: 28785879 Clinical Trial.

9

Evaluation of Model-Based Prediction of Pharmacokinetics in the Renal Impairment Population.

Yee KL, Li M, Cabalu T, Sahasrabudhe V, Lin J, Zhao P, Jadhav P. Yee KL, et al. J Clin Pharmacol. 2018 Mar;58(3):364-376. doi: 10.1002/jcph.1022. Epub 2017 Oct 27. J Clin Pharmacol. 2018. PMID: 29077203

10

Multiple Doses of Rifabutin Reduce Exposure of Doravirine in Healthy Subjects.

Khalilieh SG, Yee KL, Sanchez RI, Liu R, Fan L, Martell M, Jordan H, Iwamoto M. Khalilieh SG, et al. J Clin Pharmacol. 2018 Aug;58(8):1044-1052. doi: 10.1002/jcph.1103. Epub 2018 May 3. J Clin Pharmacol. 2018. PMID: 29723418

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

795 results

Search Page

Filters